Both in Pharmaceuticals
Generate Biomedicines vs Precigen
Over the past year GENB returned −11.5% and PGEN returned −25.0%; their daily moves had a correlation of 0.38.
GENB −11.5% PGEN −25.0%Growth of $1, one year, split-adjusted
| Metric | GENB | PGEN |
|---|---|---|
| Price | $13.92 | $5.14 |
| Market cap | $1.79B | $1.84B |
| Today | +0.51% | −2.19% |
| 1 month | +0.9% | −32.0% |
| 6 months | — | +16.7% |
| Year to date | — | +22.8% |
| 1 year | — | +23.4% |
| Revenue growth (YoY) | — | +6322.7% |
| Gross margin | 100.0% | 94.9% |
| Net margin | −1065.2% | 36.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 21.4× |
| Net cash | $452.3M | -$55.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 86.6% |
| Short % of float | 15.4% | 26.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).